Roche COVID test receives U.S. greenlight for asymptomatic people – Reuters

A logo design of Swiss pharmaceutical company Roche in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer/File PhotoRoches (ROG.S) cobas SARS-CoV-2 Test has gotten U.S. authorisation for screening individuals without symptoms or factors to think a COVID-19 infection, the Swiss drugmaker stated on Tuesday.”The high-throughput, highly delicate cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test specific or pooled samples from individuals without symptoms or other factors to think COVID-19,” Roche said in a statement.Our Standards: The Thomson Reuters Trust Principles.